EVOLVE BIOLOGICS
LIVE

Serial Number

87671420

Owner

Therapure Biopharma Inc.

Attorney

Christopher J. Schulte

Filing Date

Nov 3, 2017

Add to watchlist:

No watchlists yet
View on USPTO

EVOLVE BIOLOGICS Trademark

Serial Number: 87671420 • Registration: 6297746

EVOLVE BIOLOGICS is a trademark filed by Therapure Biopharma Inc. on November 3, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 37 (Building & Construction), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Therapure Biopharma Inc.

2585 Meadowpine Blvd.
Mississauga, Ontario L5N8H9 , CA

Entity Type: 03

Evolve Biologics Inc. (5 trademarks)

4-2855 Argentia Road
Mississauga, Ontario L5N 8G6 , CA

Entity Type: 03

Trademark Details

Filing Date

November 3, 2017

Registration Date

March 23, 2021

Published for Opposition

January 5, 2021

Goods & Services

Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics

Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods

Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate

Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities

Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 23, 2026 REM1
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Jul 7, 2021 CORV
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 1, 2021 PARI
REGISTERED-PRINCIPAL REGISTER
Mar 23, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 5, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 5, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 30, 2020 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 26, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 25, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 24, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2020 CNRT
LETTER OF PROTEST EVIDENCE FORWARDED
Jun 25, 2020 LOPT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2020 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 28, 2020 ZZZX
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Jan 27, 2020 PBSR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 14, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 10, 2020 ERSI
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 1, 2020 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 27, 2019 ASCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 19, 2019 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 19, 2019 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 19, 2019 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 18, 2019 RCCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 30, 2019 ASCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 18, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
May 18, 2019 GNSL
SUSPENSION LETTER WRITTEN
May 18, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 9, 2019 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 14, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 14, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 14, 2018 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 9, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
May 9, 2018 GNSL
SUSPENSION LETTER WRITTEN
May 9, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2018 CRFA
ASSIGNED TO LIE
May 2, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 24, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 16, 2018 GNRN
NON-FINAL ACTION E-MAILED
Feb 16, 2018 GNRT
NON-FINAL ACTION WRITTEN
Feb 16, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2017 NWOS
NEW APPLICATION ENTERED
Nov 7, 2017 NWAP